These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8424102)

  • 1. Immunopathogenic mechanisms of posttransfusion graft-vs-host disease.
    Brubaker DB
    Proc Soc Exp Biol Med; 1993 Feb; 202(2):122-47. PubMed ID: 8424102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
    van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
    Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell immunity and graft-versus-host disease (GVHD).
    Ichiki Y; Bowlus CL; Shimoda S; Ishibashi H; Vierling JM; Gershwin ME
    Autoimmun Rev; 2006 Jan; 5(1):1-9. PubMed ID: 16338205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
    Korngold R
    Bone Marrow Transplant; 1992 May; 9(5):355-64. PubMed ID: 1352163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of T cell subsets in regulating the in vivo efficacy of CTLA4-Ig in preventing graft-versus-host disease in recipients of fully MHC or multiple minor histocompatibility-disparate donor inocula.
    Blazar BR; Taylor PA; Gray GS; Vallera DA
    Transplantation; 1994 Dec; 58(12):1422-6. PubMed ID: 7809938
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation.
    Marijt EA; Veenhof WF; Goulmy E; Kluck PM; Brand A; Willemze R; van Rood JJ; Falkenburg JH
    Hum Immunol; 1993 Aug; 37(4):221-8. PubMed ID: 8300407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graft-vs.-host disease elicits expression of class I and class II histocompatibility antigens and the presence of scattered T lymphocytes in rat central nervous system.
    Hickey WF; Kimura H
    Proc Natl Acad Sci U S A; 1987 Apr; 84(7):2082-6. PubMed ID: 3550805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of exogenous interleukin-10 in a murine model of graft-versus-host disease to minor histocompatibility antigens.
    Krenger W; Snyder K; Smith S; Ferrara JL
    Transplantation; 1994 Dec; 58(11):1251-7. PubMed ID: 7992370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minors come of age: Minor histocompatibility antigens and graft-versus-host disease.
    Chao NJ
    Biol Blood Marrow Transplant; 2004 Apr; 10(4):215-23. PubMed ID: 15077220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of target injury of murine acute graft-versus-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells.
    Murphy GF; Whitaker D; Sprent J; Korngold R
    Am J Pathol; 1991 Apr; 138(4):983-90. PubMed ID: 1901455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease.
    Fontaine P; Roy-Proulx G; Knafo L; Baron C; Roy DC; Perreault C
    Nat Med; 2001 Jul; 7(7):789-94. PubMed ID: 11433342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of a T-cell line from lymphocytes presumably implicated in posttransfusion graft-versus-host disease.
    Nishimura M; Uchida S; Mitsunaga S; Tokunaga K; Mitomi Y; Tadokoro K; Juji T
    Vox Sang; 1995; 68(3):164-8. PubMed ID: 7625073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the Immunoproteasome Subunit LMP7 with ONX 0914 Ameliorates Graft-versus-Host Disease in an MHC-Matched Minor Histocompatibility Antigen-Disparate Murine Model.
    Zilberberg J; Matos J; Dziopa E; Dziopa L; Yang Z; Kirk CJ; Assefnia S; Korngold R
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1555-64. PubMed ID: 26093043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collateral damage of nonhematopoietic tissue by hematopoiesis-specific T cells results in graft-versus-host disease during an ongoing profound graft-versus-leukemia reaction.
    van der Zouwen B; Kruisselbrink AB; Frederik Falkenburg JH; Jedema I
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):760-9. PubMed ID: 24607556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allorecognition of the recipient after hematopoietic transplantation].
    Tiberghien P; Robinet E; Ferrand C; Saas P; Hervé P
    Bull Cancer; 2003; 90(8-9):706-10. PubMed ID: 14609760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human posttransfusion graft-versus-host disease.
    Brubaker DB
    Vox Sang; 1983; 45(6):401-20. PubMed ID: 6362192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting graft-versus-host disease in HLA-identical bone marrow transplant: a comparison of T-cell frequency analysis and a human skin explant model.
    Dickinson AM; Sviland L; Wang XN; Jackson G; Taylor PR; Dunn A; Proctor SJ
    Transplantation; 1998 Oct; 66(7):857-63. PubMed ID: 9798694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lethal posttransfusion graft-versus-host disease. Report of four cases.
    Matsumoto K; Kubo H; Saida T; Kobayashi H; Kitano K; Saito H; Matsui M
    Dermatology; 1993; 187(1):38-41. PubMed ID: 8324276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of minor histocompatibility antigen immunogenicity: the role of infinitesimal versus structurally profound polymorphisms.
    Brickner AG
    Immunol Res; 2006; 36(1-3):33-41. PubMed ID: 17337764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.